OrbusNeich has enrolled the first patient in a China clinical trial of its Genous Bio-engineered R stent. The stent, which has been available in Europe since 2005, is coated with an antibody that captures a patient’s endothelial progenitor cells from the bloodstream. The company says the cells promote rapid healing of the blood vessel’s lining, helping to protect against thrombus and to minimize restenosis. More details...